Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershberg
centuryofbio.com · 6,695 words · saved by 1 readers
Attempting "Moneyball for biotech"
Welcome to The Century of Biology! This newsletter explores data, companies, and ideas from the frontier of biology. You can subscribe for free to have the next post delivered to your inbox: What I initially thought would be a summer hiatus stretched into a longer break from regular writing. But I’ve now defended my PhD (🍾🍾) and am excited to have more mental bandwidth for CoB again! And I’ll have more to share about what I’m doing next… soon. 👀 For now, I’m back with a detailed profile of one of the companies I’m most intrigued by. Enjoy! 🧬 In 1994, Jeff Bezos left a high-paying…
related reading
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- Tech vs Biotech - Celine Haliouacelinehh.com
- There aren't enough smart people in biology doing something boringowlposting.com
- Curious cases of financial engineering in biotechowlposting.com
- Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
- Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio
- AI Versus Eroom's Lawsubstack.com
- Dot-com bubble - Wikipediaen.wikipedia.org
- Ginkgo Bioworks: The Organism Companynotboring.co
- The Age of Tech x Bio: The 'Industrial Bio Complex' | Andreessen Horowitza16z.com